Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models.

Cucarull B, Tutusaus A, Subías M, Stefanovic M, Hernáez-Alsina T, Boix L, Reig M, García de Frutos P, Marí M, Colell A, Bruix J, Morales A.

Cancers (Basel). 2020 Feb 1;12(2). pii: E332. doi: 10.3390/cancers12020332.

2.

Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma.

Fernández-Varo G, Perramón M, Carvajal S, Oró D, Casals E, Boix L, Oller L, Macías-Muñoz L, Marfà S, Casals G, Morales-Ruiz M, Casado P, Cutillas PR, Bruix J, Navasa M, Fuster J, Garcia-Valdecasas JC, Pavel MC, Puntes V, Jiménez W.

Hepatology. 2020 Jan 21. doi: 10.1002/hep.31139. [Epub ahead of print]

PMID:
31961955
3.

Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma.

Soto M, Reviejo M, Al-Abdulla R, Romero MR, Macias RIR, Boix L, Bruix J, Serrano MA, Marin JJG.

Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165687. doi: 10.1016/j.bbadis.2020.165687. Epub 2020 Jan 15.

PMID:
31953214
4.

Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.

Unfried JP, Serrano G, Suárez B, Sangro P, Ferretti V, Prior C, Boix L, Bruix J, Sangro B, Segura V, Fortes P.

Cancer Res. 2019 Oct 15;79(20):5167-5180. doi: 10.1158/0008-5472.CAN-19-0400. Epub 2019 Aug 6.

PMID:
31387921
5.

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents.

Sanduzzi-Zamparelli M, Boix L, Leal C, Reig M.

Viruses. 2019 May 1;11(5). pii: E406. doi: 10.3390/v11050406. Review.

6.

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.

Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, de Frutos PG, Reig M, Fernandez-Checa JC, Marí M, Colell A, Bruix J, Morales A.

Oncotarget. 2018 Mar 30;9(24):16701-16717. doi: 10.18632/oncotarget.24673. eCollection 2018 Mar 30.

7.

Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.

Urtasun N, Boces-Pascual C, Boix L, Bruix J, Pastor-Anglada M, Pérez-Torras S.

Oncotarget. 2017 Oct 6;8(52):90185-90196. doi: 10.18632/oncotarget.21624. eCollection 2017 Oct 27.

8.

Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.

Coto-Llerena M, Koutsoudakis G, Boix L, López-Oliva JM, Caro-Pérez N, Fernández-Carrillo C, González P, Gastaminza P, Bruix J, Forns X, Pérez-Del-Pulgar S.

Virus Res. 2017 Aug 15;240:35-46. doi: 10.1016/j.virusres.2017.07.018. Epub 2017 Jul 24.

PMID:
28751105
9.

Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?

Reig M, Boix L, Mariño Z, Torres F, Forns X, Bruix J.

Semin Liver Dis. 2017 May;37(2):109-118. doi: 10.1055/s-0037-1601349. Epub 2017 Apr 7. Review.

PMID:
28388736
10.

The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma.

Reig M, Boix L, Bruix J.

Liver Int. 2017 Jan;37 Suppl 1:136-139. doi: 10.1111/liv.13321. Review.

PMID:
28052619
11.

Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway.

Boix L, López-Oliva JM, Rhodes AC, Bruix J.

Oncotarget. 2016 Nov 1;7(44):71309-71329. doi: 10.18632/oncotarget.11885.

12.

Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Angheben A, Boix L, Buonfrate D, Gobbi F, Bisoffi Z, Pupella S, Gandini G, Aprili G.

Blood Transfus. 2015 Oct;13(4):540-50. doi: 10.2450/2015.0040-15. Review.

13.

Akt-mediated foxo1 inhibition is required for liver regeneration.

Pauta M, Rotllan N, Fernández-Hernando A, Langhi C, Ribera J, Lu M, Boix L, Bruix J, Jimenez W, Suárez Y, Ford DA, Baldán A, Birnbaum MJ, Morales-Ruiz M, Fernández-Hernando C.

Hepatology. 2016 May;63(5):1660-74. doi: 10.1002/hep.28286. Epub 2015 Dec 18.

14.

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer.

Barbier-Torres L, Delgado TC, García-Rodríguez JL, Zubiete-Franco I, Fernández-Ramos D, Buqué X, Cano A, Gutiérrez-de Juan V, Fernández-Domínguez I, Lopitz-Otsoa F, Fernández-Tussy P, Boix L, Bruix J, Villa E, Castro A, Lu SC, Aspichueta P, Xirodimas D, Varela-Rey M, Mato JM, Beraza N, Martínez-Chantar ML.

Oncotarget. 2015 Feb 10;6(4):2509-23.

15.

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.

Mingorance L, Friesland M, Coto-Llerena M, Pérez-del-Pulgar S, Boix L, López-Oliva JM, Bruix J, Forns X, Gastaminza P.

Antimicrob Agents Chemother. 2014 Jun;58(6):3451-60. doi: 10.1128/AAC.02619-14. Epub 2014 Apr 7.

16.

Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.

Bodro M, Gudiol C, Garcia-Vidal C, Tubau F, Contra A, Boix L, Domingo-Domenech E, Calvo M, Carratalà J.

Support Care Cancer. 2014 Mar;22(3):603-10. doi: 10.1007/s00520-013-2012-3. Epub 2013 Oct 30.

PMID:
24170166
17.

Low serum vitamin D is not associated with an increase in mortality in oldest old subjects: the Octabaix three-year follow-up study.

Formiga F, Ferrer A, Megido MJ, Boix L, Contra A, Pujol R; Octabaix study members.

Gerontology. 2014;60(1):10-5. doi: 10.1159/000351024. Epub 2013 May 15.

PMID:
23689215
18.

A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.

Huidobro C, Toraño EG, Fernández AF, Urdinguio RG, Rodríguez RM, Ferrero C, Martínez-Camblor P, Boix L, Bruix J, García-Rodríguez JL, Varela-Rey M, Mato JM, Martínez-Chantar ML, Fraga MF.

J Mol Med (Berl). 2013 Aug;91(8):939-50. doi: 10.1007/s00109-013-1010-8. Epub 2013 Mar 12.

PMID:
23475283
19.

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, Bruix J.

Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.

PMID:
22287594
20.

Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding.

Ramírez-Lázaro MJ, Lario S, Casalots A, Sanfeliu E, Boix L, García-Iglesias P, Sánchez-Delgado J, Montserrat A, Bella-Cueto MR, Gallach M, Sanfeliu I, Segura F, Calvet X.

PLoS One. 2011;6(5):e20009. doi: 10.1371/journal.pone.0020009. Epub 2011 May 20.

21.

MicroRNA analysis for outcome prediction in hepatitis B virus-related liver cancer.

Boix L, Bruix J.

Gastroenterology. 2010 Apr;138(4):1624-6; discussion 1626-7. doi: 10.1053/j.gastro.2010.02.021. Epub 2010 Feb 21. No abstract available.

PMID:
20175966
22.

alpha-Tocopherol, MDA-HNE and 8-OHdG levels in liver and heart mitochondria of adriamycin-treated rats fed with alcohol-free beer.

Valls-Belles V, Torres Mdel C, Boix L, Muñiz P, Gonzalez-Sanjose ML, Codoñer-Franch P.

Toxicology. 2008 Jul 30;249(2-3):97-101. doi: 10.1016/j.tox.2008.04.010. Epub 2008 Apr 22.

PMID:
18513847
23.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J.

Hepatology. 2008 Jan;47(1):97-104. Erratum in: Hepatology. 2008 Feb;47(2):769.

PMID:
18069697
24.

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis.

Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, Boix L, Fausto N, Bruix J, Katze MG.

Virol J. 2006 Nov 22;3:98.

25.

New aspects of diagnosis and therapy of hepatocellular carcinoma.

Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM.

Oncogene. 2006 Jun 26;25(27):3848-56. Review.

PMID:
16799626
26.

Focus on hepatocellular carcinoma.

Bruix J, Boix L, Sala M, Llovet JM.

Cancer Cell. 2004 Mar;5(3):215-9. Review. No abstract available.

27.

Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.

Armengol C, Tarafa G, Boix L, Solé M, Queralt R, Costa D, Bachs O, Bruix J, Capellá G.

Clin Cancer Res. 2004 Mar 15;10(6):2150-7.

28.

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG.

Hepatology. 2003 Dec;38(6):1458-67.

PMID:
14647057
29.

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, Nagorney DM, Gostout BS, Burgart LJ, Boix L, Bruix J, McMahon BJ, Cheung TH, Chung TK, Wong YF, Smith DI, Roberts LR.

Oncogene. 2003 Jun 12;22(24):3813-20.

PMID:
12802289
30.

p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.

Armengol C, Boix L, Bachs O, Solé M, Fuster J, Sala M, Llovet JM, Rodés J, Bruix J.

J Hepatol. 2003 May;38(5):591-7.

PMID:
12713869
31.

Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.

Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG.

Cancer Res. 2003 Feb 15;63(4):859-64.

32.

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J; Barcelona Clínic Liver Cancer (BCLC) Group.

Hepatology. 2001 May;33(5):1124-9.

PMID:
11343240
33.

Laparoscopic-assisted vs. open colectomy for colorectal cancer: influence on neoplastic cell mobilization.

Bessa X, Castells A, Lacy AM, Elizalde JI, Delgado S, Boix L, Piñol V, Pellisé M, García-Valdecasas JC, Piqué JM.

J Gastrointest Surg. 2001 Jan-Feb;5(1):66-73.

PMID:
11309650
34.

Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.

Bessa X, Elizalde JI, Boix L, Piñol V, Lacy AM, Saló J, Piqué JM, Castells A.

Gastroenterology. 2001 Apr;120(5):1084-92.

PMID:
11266372
35.

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.

Castells A, Puig P, Móra J, Boadas J, Boix L, Urgell E, Solé M, Capellà G, Lluís F, Fernández-Cruz L, Navarro S, Farré A.

J Clin Oncol. 1999 Feb;17(2):578-84.

PMID:
10080602
36.
37.

Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: relationship with hepatic hemodynamics.

Leivas A, Jiménez W, Bruix J, Boix L, Bosch J, Arroyo V, Rivera F, Rodés J.

J Vasc Res. 1998 May-Jun;35(3):186-93.

PMID:
9647333
38.

[Attempted suicide with oral diltiazem].

Sevilla F, Arruego MA, Monzón FJ, Boix L.

Med Clin (Barc). 1996 Sep 7;107(7):275. Spanish. No abstract available.

PMID:
8975098
39.

Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.

Castells A, Bruix J, Brú C, Ayuso C, Roca M, Boix L, Vilana R, Rodés J.

Gastroenterology. 1995 Sep;109(3):917-22.

PMID:
7657122
40.

Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection.

Boix L, Castells A, Bruix J, Solé M, Brú C, Fuster J, Rivera F, Rodés J.

J Hepatol. 1995 Jun;22(6):616-22.

PMID:
7560855
41.

Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

Castells A, Bruix J, Ayuso C, Brú C, Montanyà X, Boix L, Rodès J.

J Hepatol. 1995 Apr;22(4):410-5.

PMID:
7665860
42.

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.

Bruix J, Castells A, Montanyà X, Calvet X, Brú C, Ayuso C, Jover L, García L, Vilana R, Boix L, et al.

Hepatology. 1994 Sep;20(3):643-50.

PMID:
7521316
43.

nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.

Boix L, Bruix J, Campo E, Sole M, Castells A, Fuster J, Rivera F, Cardesa A, Rodes J.

Gastroenterology. 1994 Aug;107(2):486-91.

PMID:
8039626
44.

c-met mRNA overexpression in human hepatocellular carcinoma.

Boix L, Rosa JL, Ventura F, Castells A, Bruix J, Rodés J, Bartrons R.

Hepatology. 1994 Jan;19(1):88-91.

PMID:
8276372
45.

Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.

Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodés J.

Hepatology. 1993 Nov;18(5):1121-6.

PMID:
8225217
46.

Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment?

Boix L, Bruix J, Castells A, Fuster J, Bru C, Visa J, Rivera F, Rodes J.

J Hepatol. 1993 Feb;17(2):187-91.

PMID:
8383159
47.

Surgical resection and survival in Western patients with hepatocellular carcinoma.

Bruix J, Cirera I, Calvet X, Fuster J, Bru C, Ayuso C, Vilana R, Boix L, Visa J, Rodés J.

J Hepatol. 1992 Jul;15(3):350-5.

PMID:
1332998
48.

Is exocrine pancreatic cancer a hormone-dependent tumor? A study of the existence of sex hormone receptors in normal and neoplastic pancreas.

Targarona EM, Pons MD, Gonzalez G, Boix L, Marco V, Marco C.

Hepatogastroenterology. 1991 Apr;38(2):165-9.

PMID:
1855775

Supplemental Content

Support Center